Annual Shareholders Equity
$255.37 M
-$21.58 M-7.79%
31 December 2023
Summary:
Terns Pharmaceuticals annual stockholders equity is currently $255.37 million, with the most recent change of -$21.58 million (-7.79%) on 31 December 2023. During the last 3 years, it has risen by +$186.78 million (+272.30%). TERN annual shareholders equity is now -7.79% below its all-time high of $276.94 million, reached on 31 December 2022.TERN Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$364.47 M
+$145.79 M+66.67%
30 September 2024
Summary:
Terns Pharmaceuticals quarterly stockholders equity is currently $364.47 million, with the most recent change of +$145.79 million (+66.67%) on 30 September 2024. Over the past year, it has increased by +$106.05 million (+41.04%). TERN quarterly shareholders equity is now at all-time high.TERN Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TERN Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -7.8% | +41.0% |
| 3 y3 years | +272.3% | +111.7% |
| 5 y5 years | +253.6% | - |
TERN Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -7.8% | +272.3% | at high | +165.6% |
| 5 y | 5 years | -7.8% | +5970.1% | at high | +1566.8% |
| alltime | all time | -7.8% | +5970.1% | at high | +1566.8% |
Terns Pharmaceuticals Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $364.47 M(+66.7%) |
| June 2024 | - | $218.68 M(-7.6%) |
| Mar 2024 | - | $236.72 M(-7.3%) |
| Dec 2023 | $255.37 M(-7.8%) | $255.37 M(-1.2%) |
| Sept 2023 | - | $258.43 M(-5.7%) |
| June 2023 | - | $274.15 M(-4.7%) |
| Mar 2023 | - | $287.68 M(+3.9%) |
| Dec 2022 | $276.94 M | $276.94 M(+50.8%) |
| Sept 2022 | - | $183.69 M(+33.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2022 | - | $137.22 M(-7.7%) |
| Mar 2022 | - | $148.72 M(-7.2%) |
| Dec 2021 | $160.30 M(+133.7%) | $160.30 M(-6.9%) |
| Sept 2021 | - | $172.16 M(-5.1%) |
| June 2021 | - | $181.33 M(-4.6%) |
| Mar 2021 | - | $190.00 M(+177.0%) |
| Dec 2020 | $68.59 M(+1530.4%) | $68.59 M(-376.0%) |
| Sept 2020 | - | -$24.85 M(-690.6%) |
| Dec 2019 | $4.21 M(-94.2%) | $4.21 M |
| Dec 2018 | $72.23 M | - |
FAQ
- What is Terns Pharmaceuticals annual stockholders equity?
- What is the all time high annual shareholders equity for Terns Pharmaceuticals?
- What is Terns Pharmaceuticals annual shareholders equity year-on-year change?
- What is Terns Pharmaceuticals quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Terns Pharmaceuticals?
- What is Terns Pharmaceuticals quarterly shareholders equity year-on-year change?
What is Terns Pharmaceuticals annual stockholders equity?
The current annual shareholders equity of TERN is $255.37 M
What is the all time high annual shareholders equity for Terns Pharmaceuticals?
Terns Pharmaceuticals all-time high annual stockholders equity is $276.94 M
What is Terns Pharmaceuticals annual shareholders equity year-on-year change?
Over the past year, TERN annual stockholders equity has changed by -$21.58 M (-7.79%)
What is Terns Pharmaceuticals quarterly stockholders equity?
The current quarterly shareholders equity of TERN is $364.47 M
What is the all time high quarterly shareholders equity for Terns Pharmaceuticals?
Terns Pharmaceuticals all-time high quarterly stockholders equity is $364.47 M
What is Terns Pharmaceuticals quarterly shareholders equity year-on-year change?
Over the past year, TERN quarterly stockholders equity has changed by +$106.05 M (+41.04%)